Novel glycine antagonists as potent neuroprotective agents

Pharmacochemistry Library

Volumn 28, Issue C, 1997, Pages 81-95

  Gaviraghi, Giovanni ^a   Fabio, Romano Di ^a   Cugola, Alfredo ^a   Donati, Daniele ^a   Feriani, Aldo ^a   Ratti, Emiliangelo ^a   Trist, David G ^a   Reggiani, Angelo ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0003040238     PISSN: 01657208     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0165-7208(97)80055-4     Document Type: Article

References (54)

1. Meldrum B., and Garthwaite J. Excitatory Amino Acid Neurotoxicity and Neurodegenerative Diseases. Trends Pharmacol 11 (1990) 379
2. Choi D.W. Cerebral Hypoxia: Some New Approches and Unanswered Questions. J. Neurosci 10 (1990) 2493
3. Meldum B. Protection Against Ischaemic Neuronal Damage by Drugs Acting on Excitatory Neurotransmission. Cerebrovasc. Brain Metab. Rev. 2 (1990) 27
4. McCullogh J. Excitatory Amino Acid Antagonists and their Potential for the Treatment of Ischemic Brain Damage in Man. Br. J. Clin. Pharmacol. 34 (1992) 106
5. Cotman C.W., Foster A.C., and Lanthorn T.H. Adv. Biochem. Biopharmacol. 27 (1981) 1-27
6. Watchins J.C., and Evans R.H. Excitatory Amino Acids Transmitters. Ann. Rev. Pharmacol. Toxicol. 21 (1981) 165
7. Choi D.W., and Rothman S.M. The Role of Glutamate Neurotoxicity in Hypoxic-Ischemic Neuronal Death. Ann. Rev. Pharmacol. Toxicol. 31 (1991) 171
8. Wong E.H.F., and Kemp J.A. Site for Antagonism on the N-methyl-D-aspartate Receptor Channel Complex. Ann. Rev. Pharmacol. Toxicol 31 (1991) 401
9. Wong E.H.F., and Kemp J.A. Site for Antagonism on the N-methyl-D-aspartate Receptor Channel Complex. In: Meldrum B. (Ed). Excitatory Amino Acid Antagonists (1991), Blackwall, Oxford, England
10. In: Collingridge G.L., and Watkins J.C. (Eds). The NMDA Receptor. 2nd ed (1994), IRL Press, Oxford, England
11. Johnson J.W., and Ascher P. Glycine Potentiates the NMDA Receptor Reponse in Cultured Brain Mouse Neurones. Nature 325 (1987) 529
12. Reviews. Kleckner N.W., and Dingledine R. Requirements for Glycine in Activation of NMDA Receptors Expressed in Xenopus Oocytes. Science 241 (1988) 835
13. Thomson A.M. Glycine is a Coagonist at the NMDA Receptor / Ion Channel Complex. Prog. Neurobiol. 35 (1990) 53
14. Huettner J.E. Competitive Antagonism of Glycine at the N-Methyl-D-Aspartate (NMDA) Receptor. Biochem. Pharmacol. 41 (1991) 9
15. Morris R.G.M., Anderson E., Lynch G.S., and Baudry M. Selective Impairment of Learning and Blockage of Long-term Potentiation by an N-Methyl-D-Aspartate antagonist, AP5. Nature 319 (1986) 774
16. Koek W., and Colpaert F.C. Selective Blockade of N-Methyl-D-aspartate (NMDA)-induced Convulsions by NMDA Antagonists and Putative Glycine Antagonists: Relationship with Phenylcyclidine-like Behavioral Effects. J. Pharmacol. Exp. Ther.. 252 (1990) 349
17. Chiamulera C., Costa S., and Reggiani A. Effect of NMDA and Strychnine-Insensitive Glycine Site Antagonists on NMDA-Mediated Convulsions and Learning. Psycopharmacol 112 (1990) 551
18. Chapter 6. Palfreyman M.G., and Baron M.B. In: Meldrum B. (Ed). Non-competitive NMDA Antagonists Acting at the Glycine Site. In Excitatory Amino Acid Antagonists (1991), Blackwell, Oxford, England 101-129
19. Carter A.J. Glycine Antagonists: Regulation of the NMDA Receptor-Complex by the Strychnine-Insensitive Glycine Site. Drugs Future 17 (1992) 595
20. Kemp J.A., and Leeson P.D. The Glycine Site of the NMDA Receptor - Five Years On. TiPS 14 (1993) 20
21. Leeson P.D., and Iversen L.L. The Glycine Site on the NMDA receptor: Structure-Activity Relationships and Therapeutic Potential. J. Med. Chem. 37 (1994) 4053
22. Chapter 20. Iversen L.L., and Kemp J.A. Non competitive NMDA Antagonists as Drug. In: Collingridge G.L., and Watkins J.C. (Eds). The NMDA Receptor. 2nd Ed (1994), IRL Press, Oxford, England 469-486
23. Di F.R., Gaviraghi G., and Reggiani A. Strychnine-Insensitive Glycine Binding Site and the NMDA Receptor. La Chimica e l' Industria 78 (1996) 283
24. Moore K.W., Leeson P.D., Carling R.W., Tricklebank M.D., and Singh L. Anticonvulsant Activity of Glycine-Site NMDA Antagonists. 1. 2-Carboxyl Prodrugs of 5,7-Dichlorokynurenic Acid. Bioorg. Med. Chem. Lett. 3 (1993) 61
25. Carling R.W., Leeson P.D.M., Smith J.D., Saywell K., Tricklebank M.D., Kemp J.A., Marshall J.R., Foster A.C., and Grimwood S. Anticonvulsant Activity of Glycine-Site NMDA Antagonists. 2. Trans 2-Carboxy-4-Substituted Tetrahydroquinolines. Bioorg. Med. Chem. Lett. 3 (1993) 65-70
26. Reggiani A., Costa S., Pietra C., Ratti E., Trist D., Ziviani L., and Gaviraghi G. Neuroprotective Activity of GV150526A a Novel Potent and Selective Glycine Antagonist. Eur. J. Neurol. 2 (1995) 6
27. G.Reggiani A. Stroke 27 (1996) 26 Neuroprotection of GV150526A. Comparison with Reference Compounds. Pietra
28. Di F., G.Ratti E., Reggiani A., and Trist D.G. Novel Substituted Indole-2-Carboxylates as Potent Glycine Antagonists. 211th ACS National Meeting. New Orleans, LA, 24-28 March (1996) Abstract 107
29. Kishimoto H., Simon J.R., and Aprison M.H. Determination of the Equilibrium Dissociation Constants at a Number of Glycine Binding Sites in Several Areas of the Rat Central Nervous System, Using a Na-Indipendent System. J. Neurochem. 37 (1981) 1015 ACS Book of Abstracts
30. Kloog Y., Haring R., and Sokolovsky M. Kinetic Characterization of the Phenylcyclidine-N-Methyl-D-Aspartate Receptor Interaction: Evidence for Steric Blockade of the Channel. Biochemistry-US 27 (1988) 843
31. F.Gaviraghi G. Requirement of the Glycine for the Glutamate Activity at the NMDA Receptor Site. Eur. J. Pharmacol. 183 (1990) 1665
32. Van A., Giberti A., Mugnaini M., and Ratti E. 3-[(±)-2- Carboxypiperazin-4-yl]propyl-1-Phosphonic Acid Recognizes Two N-Methyl-D-Aspartate Binding Sites in Rat Cerebral Cortex Membranes. J. Neurochem. 59 (1992) 1850
33. 3H]-α- Amino-3-Hydroxy-5-Methyl-Isoxazole-4-Propionic Acid (AMPA) to Rat Cortex Membranes Reveals Two Sites or Affinity States. J. Recept. Res. 11 (1991) 727
34. 3H]Kainate Binding Sites with Different Molecular Target Sizes in Rat Cortex. Neurosci. Lett. 65 (1986) 47
35. Tamura A.; G., McCullogh J., and Teasdale G.M. Focal Cerebral Ischemia in Rat: 1. Description of Technique and Early Neuropathological Consequences. J. Cereb. Blood. Flow Metab. 1 (1981) 53
36. Huettner J.E. Indole-2-Carboxylic Acid: A Competitive Antagonist of Potentiation By Glycine at the NMDA Receptor. Science 243 (1989) 1611
37. Salituro F.G., Harrison B.L., Baron B.M., Nyce P.L., Stewart K.T., and McDonald I.A. Indole Derivatives: Antagonists of the Strychnine-Insensitive Glycine Receptor Associated with the N-Methyl- D-Aspartate Receptor Complex. J. Med. Chem. 33 (1990) 2944
38. Gray N.M., Dappen M.S., Cheng B.K., Cordi A.A., Biesterfeldt J.P., Hood W.F., and Monahan J.B. Novel Indole-2-Carboxylates as Ligands for the Strychnine-Insensitive N-Methyl-D-Aspartate-Linked Glycine Receptor. J. Med. Chem. 34 (1991) 1283
39. Salituro F.G., Tomlinson R.C., Baron B.M., Demeter D.A., Weintraub H.J.R., and McDonald I.A. Design, Synthesis and Molecular Modeling of 3-Acylamino-2-carboxyindole NMDA Receptor Glycine Site Antagonists. Bioorg. Med. Chem. Lett. 1 (1991) 455
40. Salituro F.G., Harrison B.L., Baron B.M., Nyce P.L., Stewart K.T., Kehne J.H., White H.S., and McDonald I.A. 3-(2-Carboxylindol-3-yl)propionic Acid-Based Antagonists of the N-Methyl-D-aspartic Acid Receptor Associated Glycine Binding Site. J. Med. Chem. 35 (1992) 1791
41. Rao T.S., Gray N.M., Dappen M.S., Cler J.A., Mick S.I., Emmett M.R., Iyergan S., Monahan J.B., Cordi A.A., and Wood P.L. Indole-2-Carboxylates, Novel Antagonists of the N-Methyl-D-Aspartate (NMDA)-Associated Glycine Recognition Sites: in vivo Characterization. Structure-Activity Relatioship of a Series of Glycine Antagonists Related to 5,7-Dichlorokynurenic acid and 3-(2-Carboxy-6-Chloroindol-3-yl) Acetic Acid. Neuropharmacol. 32 (1993) 139
42. Rao T.S., Gray N.M., Dappen M.S., Cler J.A., Mick S.I., Emmett M.R., Iyergan S., Monahan J.B., Cordi A.A., and Wood P.L. Indole-2-Carboxylates, Novel Antagonists of the N-Methyl-D-Aspartate (NMDA)-Associated Glycine Recognition Sites: in vivo Characterization. Bioorg. Med. Chem. Lett. 3 (1993) 81
43. Leeson P.D., Baker R., Carling R.W., Curtis N.R., Moore K.W., Williams B.J., Foster A.C., Donald A.D., Kemp J.A., and Marshall G.R. Kynurenic Acid Derivatives: Structure-Activity Relationship for Excitatory Amino Acid Antagonism and Identification of Potent and Selective Antagonists at the Glycine Site on the N-Methyl-D-Aspartate Receptor. J. Med. Chem. 34 (1991) 1243
44. Smith E.C.R., McQuaid L.A., Calligaro D., O'Malley P.J., Leeson P.D., Carling R.W., Moore K., Smith J.D., Stevenson G., Chan T., Baker R., Foster A.C., Grimwood S., Kemp J.A., Marshall G.R., and Hoogsteen K. 4-Amino-2-Carboxytetrahydroquinolines. Structure-Activity Relationship for Antagonism at the Glycine Site of the NMDA Receptor. J. Med. Chem. 35 (1992) 1954
45. Hansch C., and Leo A. Substituent constants for Correlation Analysis in Chemistry and Biology (1979), John Wiley s& Sons
46. Williams S.G., and Norrington F.E. Determination of Positional Weighting Factors for the Swain and Lupton Substituent Constants F and R. J. Am. Chem. Soc. 98 (1976) 508
47. Hammett L.P. Physical Organic Chemistry (1940), McGraw-Hill, New York
48. Hammett L.P. Physical Organic Chemistry. Physical Organic Chemistry (1970), McGraw-Hill, New York
49. Hammett L.P., Draper N.R., and Smith H. Applied Regression Analysis (1981), Wiley, New York
50. RS/1 v 4.4.1, Bolt Beranek and Newman Inc., 1992.
51. TSAR v.2.2, Oxford Molecular Ltd., 1993.
52. Daylight v4.41, Daylight Chemical Information Systems, 1995.
53. Larock R.C. Comprehensive Organic Transformations 972-976 (1989), VCH Publishers, Inc.
54. Di F., and V.Rossi T. Synthesis of Amides: An Efficient and Chemoselective Method for the Preparation of β-lactam Derivatives Related to HLE Inhibitors. Tetrahedron 49 (1993) 2239 references herein enclosed